Stay updated on SAGE-547 for Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-547 for Severe Postpartum Depression Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA general notice about government funding and site operating status has been removed. There is no impact on the study details, eligibility criteria, or trial data on this page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedThe new screenshot shows no changes to core study details; only minor UI/presentation adjustments are visible.SummaryDifference0.5%

- Check70 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check85 days agoChange DetectedReplaced Sage Therapeutics with Supernus Pharmaceuticals, Inc. and updated the page’s last-update timestamps to current dates to reflect a branding/identity update and refreshed metadata.SummaryDifference1%

Stay in the know with updates to SAGE-547 for Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Severe Postpartum Depression Clinical Trial page.